Bisphenol a increases risk for presumed non-alcoholic fatty liver disease in Hispanic adolescents in NHANES 2003–2010

Table 2 Risk of Suspected Non-Alcoholic Fatty Liver Disease (NAFLD)

Risk of Suspected NAFLD^a in total population
	All races (n = 944)				Non-hispanic white (n = 256)		Hispanic (n = 344)
	Unadjusted model^d		Adjusted model^e		Adjusted model^f		Adjusted model^f
	OR (95% C.I.)^c	p-value	OR (95% C.I.)	p-value	OR (95% C.I.)	p-value	OR (95% C.I.)	p-value
Urinary BPA^b Category
0.28–1.3 ng/mL	Reference		Reference		Reference		Reference
1.4–2.7 ng/mL	2.66 (0.94–7.48)	0.064	4.23 (1.44–12.41)	0.010	1.69 (0.26–10.92)	0.571	6.12 (1.62–23.15)	0.009
2.8–5.4 ng/mL	1.95 (0.57–6.71)	0.281	2.43 (0.57–10.43)	0.225	1.19 (0.09–15.63)	0.887	2.74 (0.42–17.70)	0.281
≥5.5 ng/mL	2.12 (0.58–7.72)	0.248	3.39 (0.78–14.80)	0.101	1.30 (0.06–27.62)	0.862	4.21 (0.74–24.11)	0.104
Log Transformed BPA
	1.07 (0.69–1.67)	0.757	1.20 (0.75–1.91)	0.444	1.22 (0.48–3.12)	0.674	1.02 (0.61–1.72)	0.937

^aNon-Alcoholic Fatty Liver Disease, ^bBisphenol A, ^cOdds Ratio (95% Confidence Interval), ^dAdjusted for urinary creatinine, ^eAdjusted for urinary creatinine, gender, age, race, family income to poverty ratio, country of birth, total caloric intake in 24 h, cotinine levels, and survey cycle, ^fAdjusted for urinary creatinine, gender, age, total caloric intake in 24 h, cotinine levels, and survey cycle

ISSN: 1476-069X